Rollins Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$456K Sell
782
-441
-36% -$257K 0.1% 71
2023
Q3
$657K Buy
1,223
+586
+92% +$302K 0.16% 61
2023
Q2
$299K Buy
+637
New +$267K 0.08% 80
2023
Q1
– Sell
-584
Closed -$214K – 127
2022
Q4
$214K Buy
+584
New +$207K 0.08% 113

Other funds holding LLY

Rollins Financial's LLY Position: Q4 2023 in Review

Rollins Financial reduced its Eli Lilly (LLY) stake by 36% in Q4 2023, selling an estimated $257K and leaving 782 shares worth $456K. The position accounts for 0.1% of the portfolio, ranked #71.

Rollins Financial first reported a position in LLY in Q4 2022 and has held it in 4 quarters since. The position peaked at $657K in Q3 2023. 3,276 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Rollins Financial held 782 shares of Eli Lilly worth $456K as of Q4 2023.
  • Rollins Financial sold 441 Eli Lilly shares in Q4 2023, an estimated $257K.
  • Eli Lilly made up 0.1% of Rollins Financial's portfolio in Q4 2023, its #71 holding.
  • Rollins Financial first reported a position in Eli Lilly in Q4 2022 and has held it in 4 quarters since.
  • Rollins Financial's Eli Lilly position peaked at $657K in Q3 2023.
  • 3,276 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Rollins Financial's 13F filing for Q4 2023, filed 6 Feb 2024.